GBCI
Glacier Bancorp, Inc.
GBCI has the edge over GS overall, supported by stronger modeled upside and stronger fundamentals.
GS
The Goldman Sachs Group, Inc.
GS's outlook is improving, though it still trails on the overall score.
GBCI Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
GBCI's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like GBCI.
GS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
GS's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like GS.
GBCI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 14x | $48.14 | — |
| Cheap | 15x | $41.07 | -15% |
| Current | 18x | $48.14 | — |
| Fair | 19x | $50.20 | +4.3% |
| Expensive | 24x | $63.13 | +31% |
Historical ranges are pointers, not guarantees.
GBCI has the edge over GS in the historical PE scenario, which offers more potential upside but is not a forecast.
GS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.6x | $528 | -42% |
| Current | 13x | $914 | — |
| Forward | 13x | $914 | — |
| Fair | 14x | $940 | +2.9% |
| Expensive | 17x | $1,214 | +33% |
Historical ranges are pointers, not guarantees.
GS's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
GBCI Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
GBCI has the edge over GS on the outlook, with more favorable valuation expectations.
GS Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for GS, with profitability improving. However, they disagree widely on these estimates.
GBCI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.48 | +30% |
| Q3 2026 | $2.67 | +31% |
| Q2 2026 | $2.44 | +27% |
| Q1 2026 | $2.14 | +15% |
| Q4 2025 | $1.99 | +19% |
| Q3 2025 | $2.04 | +26% |
| Q2 2025 | $1.92 | +17% |
| Q1 2025 | $1.86 | +6.3% |
| Q4 2024 | $1.67 | -17% |
GBCI earned $2.67 per share over the past year, up 31% from the year before.
GS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $72.35 | +4% |
| Q3 2026 | $69.58 | +41% |
| Q2 2026 | $64.82 | +43% |
| Q1 2026 | $54.75 | +27% |
| Q4 2025 | $51.32 | +27% |
| Q3 2025 | $49.22 | +44% |
| Q2 2025 | $45.37 | +45% |
| Q1 2025 | $43.08 | +68% |
| Q4 2024 | $40.54 | +77% |
GS has the edge over GBCI on earnings, with more consistent year-over-year improvement.
GBCI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $329.8M | +27% |
| Q2 2026 | $317.5M | +32% |
| Q1 2026 | $306.8M | +38% |
| Q4 2025 | $306.5M | +37% |
| Q3 2025 | $260.7M | +21% |
| Q2 2025 | $240.6M | +21% |
| Q1 2025 | $222.6M | +13% |
| Q4 2024 | $223M | +13% |
GBCI has the edge over GS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | +7.6 points |
| Q2 2026 | 39% | +12 points |
| Q1 2026 | 33% | +4.1 points |
| Q4 2025 | 25% | -8.1 points |
| Q3 2025 | 33% | +3.8 points |
| Q2 2025 | 27% | -0.2 points |
| Q1 2025 | 29% | +10 points |
| Q4 2024 | 33% | +1.5 points |
GBCI has the edge over GS on profitability, with a higher operating margin.
GS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $18.7B | +23% |
| Q2 2026 | $20.3B | +39% |
| Q1 2026 | $17.2B | +14% |
| Q4 2025 | $13.5B | -3% |
| Q3 2025 | $15.2B | +20% |
| Q2 2025 | $14.6B | +15% |
| Q1 2025 | $15.1B | +6% |
| Q4 2024 | $13.9B | +23% |
GS's revenue is growing: $18.7B last quarter, up 23% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 37% | +2 points |
| Q2 2026 | 42% | +8.1 points |
| Q1 2026 | 38% | +0.2 points |
| Q4 2025 | 44% | +5.6 points |
| Q3 2025 | 36% | +4.1 points |
| Q2 2025 | 34% | +3.2 points |
| Q1 2025 | 37% | +0.6 points |
| Q4 2024 | 38% | +18 points |
GS's operating margin was 37% last quarter, up 2 points from the same quarter a year ago.
GBCI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $149.8M | +43% |
| Q2 2026 | $111.7M | +40% |
| Q1 2026 | $74.4M | +59% |
| Q3 2025 | $104.8M | -30% |
| Q2 2025 | $79.5M | +27% |
| Q1 2025 | $46.8M | +$103.5M |
| Q3 2024 | $150.1M | +15% |
| Q2 2024 | $62.7M | -48% |
GBCI has the edge over GS on cash generation, producing positive trailing cash flow while its opponent burns cash.
GS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +72% |
| Q2 2026 | $5.6B | +7.8% |
| Q1 2026 | -$32.4B | +$5.3B |
| Q4 2025 | -$16.8B | -136% |
| Q3 2025 | $2.1B | +$40.6B |
| Q2 2025 | $5.2B | -6.8% |
| Q1 2025 | -$37.7B | -$9.2B |
| Q4 2024 | $46.2B | +$75.1B |
GS's free cash flow was −$40B over the past year, against $15.8B the year before. Free cash flow isn't a meaningful measure for financial services companies like GS.
GBCI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +86.3K shares |
| 1 year | +10% | +11.8M shares |
| 3 years | +18% | +19.5M shares |
| 5 years | +36% | +34.8M shares |
| Available history | +48% | +42M shares |
GBCI has 130M diluted shares, up 10% from a year ago.
GS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -3.8M shares |
| 1 year | -4.4% | -13.9M shares |
| 3 years | -12% | -42.8M shares |
| 5 years | -15% | -52.8M shares |
| Available history | -20% | -74.4M shares |
GS has the edge over GBCI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3B |
| Q2 2026 | $4B |
| Q1 2026 | $5B |
| Q4 2025 | $3B |
| Q3 2025 | $2B |
| Q2 2025 | $3B |
| Q1 2025 | $4.4B |
| Q4 2024 | $2B |
GS spent $15B buying back its own shares over the past year, up 32% from the year before.
GBCI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 1.1x | Healthy |
| Q3 2025 | 2.4x | Moderate |
| Q2 2025 | 3.6x | Elevated |
| Q1 2025 | 4.7x | High |
| Q4 2024 | 6.5x | High |
GBCI has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like GBCI.
GS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -5.4x | Net Cash |
| Q2 2026 | -6.1x | Net Cash |
| Q1 2026 | -6.7x | Net Cash |
| Q4 2025 | -6.4x | Net Cash |
| Q3 2025 | -3.5x | Net Cash |
| Q2 2025 | -3.1x | Net Cash |
| Q1 2025 | -3.9x | Net Cash |
| Q4 2024 | -4.7x | Net Cash |
GS has the edge over GBCI on leverage, with a lower net debt burden relative to earnings.
GBCI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.0 | Neutral |
| Stochastic | 66.4 | Neutral |
GBCI's weekly RSI is 53 (neutral) and its Stochastic is 66 (neutral).
GS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.5 | Neutral |
| Stochastic | 16.3 | Oversold |
GS's weekly RSI is 45 (neutral) and its Stochastic is 16 (oversold).
GBCI PE vs Financial Services Sector
| Metric | GBCI | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 13x | 38% above |
| PE % | 39 | 63 | 24 pts below |
GBCI is trading at 18x earnings, a 38% premium to the Financial Services sector's median of 13x.
GS PE vs Financial Services Sector
| Metric | GS | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 0.8% above |
| PE % | 46 | 63 | 17 pts below |
GS has the edge over GBCI on valuation relative to its sector.
GBCI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $46.0 | 4.7% above |
| 20 week MA | $47.7 | 0.9% above |
| 50 week MA | $47.4 | 1.5% above |
| 100 week MA | $46.4 | 3.8% above |
| 200 week MA | $42.7 | 13% above |
GBCI has the edge over GS on trend strength, trading above more of its moving averages.
GS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $895.5 | 2% above |
| 20 week MA | $977.4 | 6.5% below |
| 50 week MA | $945.4 | 3.4% below |
| 100 week MA | $804.5 | 14% above |
| 200 week MA | $602.7 | 52% above |
GS's trend is mixed: it's above three of its five weekly moving averages, and 52% above its 200-week average.
GBCI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $45.9 | $45.9 | -0.1% |
| 2021 | $45.9 | $56.0 | +22% |
| 2022 | $56.0 | $49.3 | -12% |
| 2023 | $49.3 | $41.3 | -16% |
| 2024 | $41.3 | $50.3 | +22% |
| 2025 | $50.3 | $45.5 | -9.5% |
| 2026 YTD | $45.5 | $48.1 | +5.8% |
GBCI has the edge over GS on returns for 2026, with the stronger performance.
GS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $230.7 | $256.2 | +11% |
| 2021 | $256.2 | $385.0 | +50% |
| 2022 | $385.0 | $345.5 | -10% |
| 2023 | $345.5 | $385.8 | +12% |
| 2024 | $385.8 | $576.2 | +49% |
| 2025 | $576.2 | $907.0 | +57% |
| 2026 YTD | $907.0 | $913.6 | +0.7% |
GS has finished higher in five of the last six years, two of them by more than 50%. It's up 0.7% so far in 2026.